184 related articles for article (PubMed ID: 33676027)
1. Loss of mitochondrial aconitase promotes colorectal cancer progression via SCD1-mediated lipid remodeling.
You X; Tian J; Zhang H; Guo Y; Yang J; Zhu C; Song M; Wang P; Liu Z; Cancilla J; Lu W; Glorieux C; Wen S; Du H; Huang P; Hu Y
Mol Metab; 2021 Jun; 48():101203. PubMed ID: 33676027
[TBL] [Abstract][Full Text] [Related]
2. Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN.
Ran H; Zhu Y; Deng R; Zhang Q; Liu X; Feng M; Zhong J; Lin S; Tong X; Su Q
J Exp Clin Cancer Res; 2018 Mar; 37(1):54. PubMed ID: 29530061
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional Repression of SIRT3 Potentiates Mitochondrial Aconitase Activation to Drive Aggressive Prostate Cancer to the Bone.
Sawant Dessai A; Dominguez MP; Chen UI; Hasper J; Prechtl C; Yu C; Katsuta E; Dai T; Zhu B; Jung SY; Putluri N; Takabe K; Zhang XH; O'Malley BW; Dasgupta S
Cancer Res; 2021 Jan; 81(1):50-63. PubMed ID: 33115805
[TBL] [Abstract][Full Text] [Related]
4. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
Du X; Wang QR; Chan E; Merchant M; Liu J; French D; Ashkenazi A; Qing J
Cancer Res; 2012 Nov; 72(22):5843-55. PubMed ID: 23019225
[TBL] [Abstract][Full Text] [Related]
5. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial aconitase controls adipogenesis through mediation of cellular ATP production.
Chen Y; Cai GH; Xia B; Wang X; Zhang CC; Xie BC; Shi XC; Liu H; Lu JF; Zhang RX; Zhu MQ; Liu M; Yang SZ; Yang Zhang D; Chu XY; Khan R; Wang YL; Wu JW
FASEB J; 2020 May; 34(5):6688-6702. PubMed ID: 32212192
[TBL] [Abstract][Full Text] [Related]
7. A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.
Liu S; Sun X; Wang M; Hou Y; Zhan Y; Jiang Y; Liu Z; Cao X; Chen P; Liu Z; Chen X; Tao Y; Xu C; Mao J; Cheng C; Li C; Hu Y; Wang L; Chin YE; Shi Y; Siebenlist U; Zhang X
Gastroenterology; 2014 Oct; 147(4):847-859.e11. PubMed ID: 24931456
[TBL] [Abstract][Full Text] [Related]
8. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA PRKCQ-AS1 promotes CRC cell proliferation and migration via modulating miR-1287-5p/YBX1 axis.
Cui G; Zhao H; Li L
J Cell Biochem; 2020 Oct; 121(10):4166-4175. PubMed ID: 32619070
[TBL] [Abstract][Full Text] [Related]
10. Molecular Hydrogen Inhibits Colorectal Cancer Growth via the AKT/SCD1 Signaling Pathway.
Zhang X; Tao G; Zhao Y; Xing S; Jiang J; Liu B; Qin S
Biomed Res Int; 2022; 2022():8024452. PubMed ID: 35528164
[TBL] [Abstract][Full Text] [Related]
11. Stearoyl-CoA desaturase 1 inhibition impairs triacylglycerol accumulation and lipid droplet formation in colorectal cancer cells.
Tracz-Gaszewska Z; Sowka A; Dobrzyn P
J Cell Physiol; 2023 Dec; 238(12):2888-2903. PubMed ID: 37814830
[TBL] [Abstract][Full Text] [Related]
12. Aconitase 2 inhibits the proliferation of MCF-7 cells promoting mitochondrial oxidative metabolism and ROS/FoxO1-mediated autophagic response.
Ciccarone F; Di Leo L; Lazzarino G; Maulucci G; Di Giacinto F; Tavazzi B; Ciriolo MR
Br J Cancer; 2020 Jan; 122(2):182-193. PubMed ID: 31819175
[TBL] [Abstract][Full Text] [Related]
13. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of dopamine receptor D2 promotes colorectal cancer progression by activating the β-catenin/ZEB1 axis.
Lee H; Shim S; Kong JS; Kim MJ; Park S; Lee SS; Kim A
Cancer Sci; 2021 Sep; 112(9):3732-3743. PubMed ID: 34118099
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.
Fritz V; Benfodda Z; Rodier G; Henriquet C; Iborra F; Avancès C; Allory Y; de la Taille A; Culine S; Blancou H; Cristol JP; Michel F; Sardet C; Fajas L
Mol Cancer Ther; 2010 Jun; 9(6):1740-54. PubMed ID: 20530718
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of the mitochondrial metabolic enzyme aconitase (ACO2) is associated with poor prognosis in gastric cancer.
Wang P; Mai C; Wei YL; Zhao JJ; Hu YM; Zeng ZL; Yang J; Lu WH; Xu RH; Huang P
Med Oncol; 2013 Jun; 30(2):552. PubMed ID: 23550275
[TBL] [Abstract][Full Text] [Related]
17. Decreased Expression of MPC2 Contributes to Aerobic Glycolysis and Colorectal Cancer Proliferation by Activating mTOR Pathway.
Kuerbanjiang M; Gu L; Xu C; Xu WT; Wen S; Xue H; Xu Q
J Immunol Res; 2021; 2021():6618837. PubMed ID: 33791391
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitor.
Nishizawa S; Sumi H; Satoh Y; Yamamoto Y; Kitazawa S; Honda K; Araki H; Kakoi K; Imamura K; Sasaki M; Miyahisa I; Satomi Y; Nishigaki R; Hirayama M; Aoyama K; Maezaki H; Hara T
Eur J Pharmacol; 2017 Jul; 807():21-31. PubMed ID: 28442322
[TBL] [Abstract][Full Text] [Related]
19. Stearoyl-CoA desaturase-1 mediated cell apoptosis in colorectal cancer by promoting ceramide synthesis.
Chen L; Ren J; Yang L; Li Y; Fu J; Li Y; Tian Y; Qiu F; Liu Z; Qiu Y
Sci Rep; 2016 Jan; 6():19665. PubMed ID: 26813308
[TBL] [Abstract][Full Text] [Related]
20. Targeting HIBCH to reprogram valine metabolism for the treatment of colorectal cancer.
Shan Y; Gao Y; Jin W; Fan M; Wang Y; Gu Y; Shan C; Sun L; Li X; Yu B; Luo Q; Xu Q
Cell Death Dis; 2019 Aug; 10(8):618. PubMed ID: 31409769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]